AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 45 filers reported holding AURA BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,726,993 | -28.1% | 526,978 | -1.0% | 4.02% | -29.7% |
Q2 2023 | $6,574,313 | +30.3% | 532,333 | -2.1% | 5.72% | -6.4% |
Q1 2023 | $5,045,304 | -13.3% | 543,675 | -1.9% | 6.11% | -8.7% |
Q4 2022 | $5,820,003 | +43.0% | 554,286 | +146.8% | 6.69% | +34.1% |
Q3 2022 | $4,069,000 | +12.8% | 224,554 | -11.8% | 4.99% | +28.6% |
Q2 2022 | $3,608,000 | – | 254,622 | – | 3.88% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $51,617,000 | 12.92% |
Matrix Capital Management Company, LP | 4,112,870 | $69,837,000 | 0.78% |
Rock Springs Capital Management LP | 1,008,114 | $17,118,000 | 0.40% |
Nantahala Capital Management | 99,146 | $1,683,000 | 0.06% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,255,480 | $21,318,000 | 0.04% |
Citadel Advisors | 2,315,102 | $37,318,000 | 0.01% |
CAAS CAPITAL MANAGEMENT LP | 10,000 | $170,000 | 0.00% |
Concord Wealth Partners | 150 | $3,000 | 0.00% |
Allianz Asset Management GmbH | 55,145 | $936,000 | 0.00% |
FMR LLC | 471,300 | $8,003,000 | 0.00% |